Preparation and evaluation of liposome-encapsulated codrug LMX

International Journal of Pharmaceutics

Volumn 438, Issue 1-2, 2012, Pages 240-248

  Zhong, Yan ^a   Wang, Jing ^b   Wang, Yao ^b   Wu, Bin ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Bioavailability; Codrug; Lamivudine, Ursolic acid; Liposomes; LMX

Indexed keywords

LAMIVUDINE; LIPOSOME; URSOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG DESIGN; DRUG MECHANISM; DRUG RELEASE; DRUG SCREENING; DRUG SYNTHESIS; FILM; HEPATITIS B VIRUS; HYDRATION; IN VITRO STUDY; LIVER INJURY; LIVER PROTECTION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL AVAILABILITY; DRUG COMBINATIONS; DRUG COMPOUNDING; DRUG STABILITY; INTESTINAL ABSORPTION; LAMIVUDINE; LIPOSOMES; PARTICLE SIZE; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TRITERPENES;

EID: 84867404818     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.08.051     Document Type: Article

References (43)

1. A.W.G. Alani, Y. Bae, D.A. Rao, and G.S. Kwon Polymeric micelles for the pH-dependent controlled, continuous low dose release of paclitaxel Biomaterials 31 2010 1765 1772
2. A. Ariën, C. Goigoux, C. Baquey, and B. Dupuy Study of in vitro and in vivo stability of liposomes loaded with calcitonin or indium in the gastrointestinal tract Life Sci. 53 1993 1279 1290
3. A. Ariën, N. Henry-Toulmé, and B. Dupuy Calcitonin-loaded liposomes: stability under acidic conditions and bile salts-induced disruption resulting in calcitonin-phospholipid complex formation Biochim. Biophys. Acta 1193 1994 93 100
4. B.J. Aungust Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism J. Pharm. Sci. 82 1993 979 987
5. K. Avgoustakis, A. Beletsi, and Z. Panagi PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties J. Control. Release 79 2002 123 135
6. U. Bhardwaj, and D.J. Burgess Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone Int. J. Pharm. 388 2010 181 189
7. E. Bjornesson, and R. Olsson Suspected drug-induced liver fatalities reported to the WHO database Dig. Liver Dis. 38 2006 33 38
8. C. Cha, and R.P. Dematteo Molecular mechanisms in hepatocellular carcinoma development Best Pract. Res. Clin. Gastroenterol. 19 2005 25 37
9. Y.F. Chen, and T. Ju Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B Int. J. Infect. Dis. 16 2011 e152 e158
10. Y.W. Cho, J. Lee, S.C. Lee, K.M. Huh, and K. Park Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles J. Control. Release 97 2004 249 257
11. M. Cócera, O. López, and J.L. Coderch Alterations in stratum corneum lipid liposomes due to the action of Triton X-100: influence of the level of ceramides on this process J. Control. Release 68 2000 387 396
12. M.S. El-Samaligy, N.N. Afifi, and E.A. Mahmoud Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation Int. J. Pharm. 308 2006 140 148
13. D. Ganem, and A.M. Prince Hepatitis B virus infection-natural history and clinical consequences N. Engl. J. Med. 350 2004 1118 1129
14. S.H. Gao, G.R. Fan, Z.Y. Hong, X.P. Yin, S.L. Yang, and Y.T. Wu HPLC determination of polydatin in rat biological matrices: application to pharmacokinetic studies J. Pharm. Biomed. Anal. 41 2006 240 245
15. M. Glavas-Dodov, E. Fredro-Kumbaradzi, K. Goracinova, M. Simonoska, S. Calis, S. Trajkovic-Jolevska, and A.A. Hincal The effects of lyophilization on the stability of liposomes containing 5-FU Int. J. Pharm. 291 2005 79 86
16. S.T. Goldstein, F. Zhou, S.C. Hadler, B.P. Bell, E.E. Mast, and H.S. Margolis A mathematical model to estimate global hepatitis B disease burden and vaccination impact Int. J. Epidemiol. 34 2005 1329 1339
17. G. Gregoriadis Overview of liposomes J. Antimicrob. Chemother. 28 1991 39 48
18. G. Gregoriadis Liposome Technology 2nd ed. 1993 CRC Press Boca Raton, FL, USA
19. J. Guo, Q. Ping, and Y. Chen Pharmacokinetic behavior of cyclosporine A in rabbits by oral administration of lecithin vesicle and sandimmun neoral Int. J. Pharm. 216 2001 17 21
20. I. Gutierro, R.M. Hernandez, and M. Igartua Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres Vaccine 21 2002 67 77
21. R. Jabara, N. Chronos, D. Conway, W. Molema, and K. Robinson Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating JACC: Cardiovasc. Int. 1 2008 81 87
22. I.P. Julie, C. Dawn, R. Rezvan, Y. Nancy, D.B. Susan, S.W. John, and M.H. Christine Drug-induced liver injury following positive drug rechallenge Regul. Toxicol. Pharmacol. 54 2009 84 90
23. A.L. Klibanov, and L. Huang Long-circulating liposomes: development and perspectives Liposome Res. 2 1992 321 334
24. S. Kwon, J.H. Park, H. Chung, I.C. Kwon, and S.Y. Jeong Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5β-cholanic acid Langmuir 19 2003 10188 10193
25. B. Li, S. Li, Y. Tan, D.B. Stolz, S.C. Watkins, L.H. Block, and L. Huang Lyophilization of cationic lipid-protamine-DNA (LPD) complex J. Pharm. Sci. 89 2000 355 364
26. J. Liu Pharmacology of oleanolic acid and ursolic acid J. Ethnopharmacol. 49 1995 57 68
27. M. Mobed, and T.M. Chang Comparison of polymerically stabilized PEGgrafted liposomes and physically adsorbed carboxymethylchitin and carboxymethyl/glycolchitin liposomes for biological applications Biomaterials 19 1998 1167 1177
28. A.O. Nornoo, and D.S.L. Chow Cremophor-free intravenous microemulsions for paclitaxel II. Stability, in vitro release and pharmacokinetics Int. J. Pharm. 349 2008 117 123
29. A.Y. Ozer, and H. Talsma Preparation and stability of liposomes containing 5-fluorouracil Int. J. Pharm. 55 1989 185 191
30. E. Pupo, A. Padron, E. Santana, J. Sotolongo, D. Quintana, S. Duenas, C. Duarte, M.C. de la Rosa, and E. Hardy Preparation of plasmid DNA-containing liposomes using a high-pressure homogenization extrusion technique J. Control. Release 104 2005 379 396
31. Y.H. Shih, Y.C. Chein, J.Y. Wang, and Y.S. Fu Ursolic acid protects hippocampal neurons against kainate-induced excitotoxicity in rats Neurosci. Lett. 362 2004 136 140
32. P.L. Soo, L. Luo, D. Maysinger, and A. Eisenberg Incorporation and release of hydrophobic probes in biocompatible polycaprolactone-block- poly(ethylene oxide) micelles: implications for drug delivery Langmuir 18 2002 9996 10004
33. G. Stensrud, A.S. Sande, S. Kristensen, and G. Smistad Formulation and characterisation of primaquine loaded liposomes prepared by a pH gradient using experimental design Int. J. Pharm. 198 2000 213 228
34. P.J. Stevens, and R.J. Lee Formulation kit for liposomal doxorubicin composed of lyophilised liposomes Anticancer Res. 23 2003 439 442
35. V.P. Torchilin, T.S. Levchenko, A.N. Lukyanov, B.A. Khaw, A.L. Klibanov, R. Rammohan, G.P. Samokhin, and K.R. Whiteman p-Nitrophenylcarbonyl-PEG-PE- liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups Biochim. Biophys. Acta 1511 2001 397 411
36. J.K. Vasir, K. Tambwekar, and S. Garg Bioadhesive microspheres as a controlled drug delivery system Int. J. Pharm. 255 2003 13 32
37. Z. Vlasta, K. Martina, M. Marta, K. Peter, T. Natália, L. Gábor, T. Milan, P. Božena, B. Peter, and F. Martin Synthesis and characterization of polymeric nanospheres loaded with the anticancer drug paclitaxel and magnetic particles J. Magn. Magn. Mater. 321 2009 1613 1616
38. C. Washington Drug release from microdisperse systems: a critical review Int. J. Pharm. 58 1990 1 12
39. W.J. Xiao, X. Chen, L. Yang, Y.Q. Mao, Y.Q. Wei, and L.J. Chen Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome Int. J. Pharm. 393 2010 119 126
40. Y.Y. Xiao, Y.M. Song, Z.P. Chen, and Q.N. Ping Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs Int. J. Pharm. 319 2006 162 168
41. W.C. Zamboni Liposomal, nanoparticle, and conjugated formulations of anticancer agents Clin. Cancer Res. 11 2005 8230 8234
42. Y. Zhong, Z.H. Dai, Y. Xu, Y.B. Teng, and B. Wu Synthesis, stability and pharmacological evaluation of a novel codrug consisting of lamivudine and ursolic acid Eur. J. Pharm. Sci. 45 2012 110 115
43. F. Zoulim, and S. Locarnini Management of treatment failure in chronic hepatitis B J. Hepatol. 56 2012 S112 S122